Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
America's Cultivation Corridor America's Cultivation Corridor is focused on building opportunities for agricultural bioscience research, innovation and entrepreneurship in Iowa. Together, we are working to enhance agricultural sustainability and accelerate business development by attracting new companies, talent and capital to Iowa. Through new scientific discovery and research, experts in the Corridor are forging new pathways to energy independence, sustainable food and feed, and innovative products made from renewable resources. Subscribe to our newsletter > cultivationcorridor.org/subscribe Innovation Infrastructure, Agbioscience, Biorenewables, Biotechnology, Advanced Manufacturing, Startup, Agtechnology, and Plant Sciences Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 16 | 0 | 17 | 6 | |
The Netherlands Cancer Institute Today's research for tomorrow's cure The Netherlands Cancer Institute (Het Nederlands Kanker Instituut, NKI) is an exciting and rewarding place to work. It is an internationally recognized center of scientific excellence in many key areas relating to cancer. The NKI also stands out as the only official Comprehensive Cancer Center in The Netherlands. The combination of a research institute and a dedicated cancer clinic (the Antoni van Leeuwenhoek hospital) under one roof facilitates the translation of basal research to clinical applications. It also ensures that our researchers are aware of the most urgent questions our oncologists come across in the … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 7 | 1 | 1 | 651 | |
SOLADIS by Efor Committed to Excellence Soladis has been working for more than 20 years in the management of projects related to the use of data, supporting large accounts and SMEs in France and abroad. In 2021, Soladis will join the Efor group, the European leader in Life Sciences consulting, thus bringing its recognized expertise in digital and data and strengthening its clinical offer with a full service CRO: Soladis Clinical Studies. With more than 2500 employees in 21 offices in France, Belgium, Switzerland, and the USA, we leverage our expertise and methods to assist our clients in securing the market approval and … Type: SMB Activities: biotech deeptech Technologies: Data Analytics A.I. A.I. - Deep Learning A.I. - Machine Learning | 13 | 5 | 6 | 82 | |
DE SANGOSSE #PositiveProduction ugcfugcbjs b çpùhrvpçha npnv pnaze cv Öj Öj on Oj ^j ̈jo Öj on oj ̈Oj ̈o onuov iyvi g ug ogh ih IPhPIhiphPihoighbbbbuj Technologie sur appâts, Adjuvants, Produits de Protection des Plantes Conventionnels et de Biocontrôle, and Nutrition spécialisée des cultures | 18 | 4 | 11 | 241 | |
Groupe Grimaud [Automatic translation follows] Caring for life "Entreprendre dans les Sciences de la Vie". Develop efficient and sustainable responses to global food needs, health and the good balance of living things. Genetic selection and sale of animal breeders and Biopharmacy serving human and animal health Type: SMB Activities: biotech foodtech Technologies: Decarbonization | 5 | 2 | 2 | 69 | |
Cellvax Cellvax, founded in 2001, is a preclinical biotech company which provides in vitro and in vivo studies allowing accelera Cellvax, founded in 2001, is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases, mainly in Cancer and Osteoarthritis (OA) fields. Cellvax is a fast-growing technology-driven preclinical service company. Today, Cellvax directly employs and through R&D collaborations motivated and differently skilled scientists and engineers, working in interdisciplinary teams on several innovative products. Preclinical studies CRO, Animal models, Cancer, Osteoarthritis, Bio-markers, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 7 | |
NATINOV La culture du végétal NATINOV specializes in plant extraction and the development of liquid and dry extracts from plants known for human or animal well-being. Thanks to its privileged position in the heart of France’s main region for the production of plants for health, beauty and well-being, NATINOV has developed expertise ranging from the supply of plants to the design of natural ingredients for nutraceutical, cosmetic and pharmaceutical applications, and also for animal nutrition. For the food supplements sector, its expertise also includes the formulation of customized finished products made from dry or liquid extracts. Type: SMB Activities: biotech deeptech foodtech healthtech Technologies: Bio sourced materials | 0 | 0 | 0 | 21 | |
Phodé The science of olfaction at the service of pleasure and Better-Being Phodé is an independent family business. Created in 1996 by its current CEO Daniel Eclache, we are based in the south-west of France, in Albi. Phodé is an atypical company, R&D is the beating heart of the company: for 25 years, we have been studying the impact of olfactory molecules on the brain. Today, we have succeeded in demonstrating how olfaction can positively influence the perception that living beings (humans or animals) have of their environment. Our research aims to identify and better understand the effects of sensory molecules … Type: SMB Activities: biotech Technologies: Bio sourced materials | 7 | 0 | 7 | 92 | |
CHELATEC Reliable partner for reliable molecules Chelatec is a client oriented Contract Research Organization (CRO) specializing in radioactive labelling and preclinical investigations. Our mission is to assist the pharmaceutical and biotechnology industry along the drug development process by using the radioactive tracer in non-clinical studies (ADME/PK) and bioanalyses (immunoassays). Our services include: - Custom Radiolabelling (177Lu, 90Y, 111In, 225Ac, 161Tb...) - In vitro assays - In vivo ADME/PK - Radiopharmaceuticals services Radiolabeling, In vitro bioanalyses, in vivo ADME/PK, and R&D support in Radiopharmaceuticals Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 14 | |
ATLANSTAT A MULTI-SKILLED, STRATEGIC AND OPERATIONAL PARTNER IN CLINICAL RESEARCH AND DEVELOPMENT A MULTI-SKILLED, STRATEGIC AND OPERATIONAL PARTNER IN CLINICAL RESEARCH AND DEVELOPMENT ATLANSTAT offers a comprehensive range of research and clinical development services to the human and veterinary pharmaceutical industries, agri-food, biotechnology and medical device companies. As a true partner, ATLANSTAT works closely with its clients to find solutions for the challenges they face to achieve their scientific and regulatory objectives. CRO, Biostatistics, Biotechnology, Medical devices, Data management, Clinical Research, Clinical Operations, Clinical Monitoring, Medical Writing, and Data Science Type: SMB Activities: biotech deeptech Technologies: Data Analytics | 1 | 1 | 1 | 29 | |
NEUROFIT Providing efficient preclinical research models for central nervous system and peripheral nervous system disorders. NEUROFIT, founded in 1996, is a pre-clinical CRO (Contract Research Organization) based in France and offering a comprehensive list of disease models and screening assays in the fields of psychiatry, neurology, multiple sclerosis, diabetes and pain. Neurofit works for major pharmaceutical and Biotech companies in Europe and the USA. Neurofit’s core expertise in CNS and PNS includes animal behavior techniques, nerve conduction velocity measure, nerve fiber morphometry, primary neuronal cell cultures. Neurofit has long-standing experiences in psychiatric, neurodegenerative and autoimmune / inflammatory disorders. Our disease models … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 0 | 1 | 31 | |
Eurofins Environment Testing France Testing for Life Eurofins Scientific is an international life sciences company which provides a unique range of analytical testing services to clients across multiple industries. The Group believes it is the world leader in food, environment and pharmaceutical products testing and that it is also one of the global independent market leaders in certain testing and laboratory services for agroscience, genomics, discovery pharmacology and for supporting clinical studies. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA. The Eurofins Group is a leading provider of testing and analytical services … | 7 | 3 | 4 | 498 | |
CLINACT Contract Research Organisation CLINACT, a MultiHealth Group company, is a Contract Research Organisation (CRO) assisting you in your health products development: pharmaceutical, medical devices, biotechnology, cosmetics, nutrition... With more than 20 years of experience, CLINACT provides its expertise for large range of innovative services: - Clinical operations - Biometrics - Medical and regulatory affairs - Pharmacovigilance, medical device vigilance and other vigilances - E-tools : Clinfile - Outsourcing and recruting : TempoPHARMA - Professional Training : FORMATIS This range of services fully covers industrials or academic organisations' requirements. As a MultiHealth company, CLINACT can also provide specific services withtout any … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 7 | 0 | 7 | 113 | |
ClinSearch - CAST® - EDClinTM Supporting your innovations in Europe since 1999 ClinSearch is a European Health Research Organization which provides Consultancy and Operational services for Medical Device and Drug Development. ClinSearch is committed to offering cost-effective solutions for designing and managing clinical evaluations, real-life studies or any other healthcare assessment. This is why ClinSearch is known as a company committed to results and has earned a reputation for delivering practical, measurable and high added-value data. Consultancy & Strategy, Clinical Development Plan, Project Management, CE marking, Marketing authorization, Reimbursement dossiers, HEOR, Market Access, Monitoring, EDC, Acceptability, Accelerated patient recruitment, Biostatistics, SAS programming, Medical writing, and … Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics | 0 | 0 | 0 | 89 | |
Agro-Bio Antibodies Our specificity, your antibodies Pioneer in antibodies’ field, Agro-Bio provides you its expertise and its know-how for production, development and characterization of antibodies. For over 40 years, our team supports pharmaceutical and in vitro diagnostic industries as well as public institutions for their immunology issues. We collaborate both to offer you the most suitable and effective solution. Our goal is the success of your projects. Our services around antibody: • Bioanalysis/Biopharma: o Anti-idiotypic antibodies for positive control, PK and potency test, o Host Cell Protein issue management: specific anti-HCP antibodies, 2D Western Blot coverage analysis, specific ELISA kit, o Epitope … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 45 | |
Oroxcell Highlight Innovation Oroxcell is an independent research organization (CRO) offering research services assessing the safety, toxicity and efficacy of active ingredients and finished formulations. Specialized in in-vitro testing, particularly in 3D Human Models, Oroxcell is developing its business on two fronts: • Safety & efficacy testing: From screening to GLP Compliant studies, we provide well established In-vitro platform, 2D and 3D models, for performing routine and regulatory safety testing, ADME (Absorption, Distribution, Metabolism, and Elimination) and Toxicity (sensitization, phototoxicity and genotoxicity) tests, bioanalytical studies, for evaluating pharmaceuticals, medical devices, cosmetics, nutraceuticals, home care and chemical products. • Research & Innovation: … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 0 | 14 | |
Statitec Biostatistics and clinical data management expert since 1996 Statitec was created in 1996 in order to overcome the need to develop complex statistical methodologies in both public and private sectors. In 22 years, Statitec has developed an expertise and is now leader in France in biometrics and statistical methodology dedicated to clinical research. The goal of Statitec is to meet the growing needs of clinical trial sponsors and health authorities for reliable statistical testing with indisputable results In 2017, Statitec joined the Multihealth Group to continue its international development. Statitec benefits from the support of Multihealth Group companies: - CLINACT … Type: SMB Activities: biotech deeptech Technologies: Data Analytics | 3 | 0 | 3 | 5 | |
GENEPEP - PEPTIDE Peptide Chemistry company for design, synthesis, stability studies and chemical optimisation (SAR studies)- CIR agrement PEPTIDES, PEPTIDE LIBRARIES AND PROTEINS Innovative chemistry for therapeutic, diagnostic and cosmetic applications GENEPEP is a CRO company (with CIR agreement) focused on peptide synthesis & services : - Tools for nanoparticles & surface functionalization - Custom synthesis of peptides, proteins & peptide libraries - Catalog of toxins, peptides & pseudopeptides - Design & synthesis for SAR studies (optimisation of solubility, stability, efficacy,...) - Stability & solubility tests - Partner of European programs, ANR, FUI etc... Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 14 | |
BIO-HC The cosmetic expertise from the ingredient to the finished product Specialized in the assessment of finished cosmetic products, ingredients and cosmetic raw materials, we perform tolerance and efficacy studies. BIO-HC in-vitro : toxicological and pharmacological tests on cell models (primary cells, cell lines) and tissue models (epidermis, skin reconstructed in vitro). In vitro tests, GLP studies, and OECD tests Type: SMB Activities: cosmetics biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 2 | |
GALENIX INNOVATIONS Galenix, a Key pharmaceutical R&D partner, helps you to reduce your timeline by offering innovative solutions DRUG DELIVERY SOLUTIONS - DRUG PRODUCT DEVELOPMENT - LICENSING-OUT OPPORTUNITIES Galenix provides a range of full R&D pharmaceutical services and Drug Delivery Solutions to health companies for fast access of their products on the market. ●●● From the sourcing of the API through the Drug Product development process, including preformulation, formulation, to clinical supplies, quality control, ICH stabilities and regulatory dossier submission for Europe and US FDA registration. Galenix provides its customers drug products “ready to launch” holding a Marketing Authorization. ●●● Galenix Innovations … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 10 | |
Telemedicine Technologies #ClinicalResearch #ClinicalTrials #Telemedicine, #MobileHealth #MedicalDevices #DataManagement #DataEngineering Founded in 2000, Telemedicine Technologies is an information systems engineering company specialising in the e-health sector. The solutions developed and operated by Telemedicine Technologies contribute to the improvement of the health care system, patient care or clinical and epidemiological research, in a wide range of uses. Telemedicine Technologies' activity is at the convergence of various disciplines (software engineering, space technologies, big data and data science, medicine and clinical operations, etc.) in an international environment and a start-up spirit. Telemedicine Technologies' teams have the expertise to ensure and guarantee a perfect compliance with the … Type: SMB Activities: biotech deeptech healthtech it services Technologies: Data Analytics | 11 | 0 | 11 | 33 | |
RCTs Partenaire de l’innovation médicale RCTs is a French and International Full-Service CRO with more than 30 years of experience and over 700 projects conducted: clinical studies from phase I to phase IV, real-life or public health impact studies, medical and administrative assessments of SNDS (National Health Data System) databases, in various therapeutic areas (oncology, diabetes, cardiology, rheumatology, infectious diseases, central nervous system, vaccines...), for drug and medical device manufacturers, as well as for academic sponsors, institutions, learned societies and patient associations. Besides, RCTs has an expertise in clinical evaluations (CEP and CER) and regulatory consulting for medical devices. It is … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 7 | 0 | 7 | 47 | |
BIOSYNEX Diagnostics Innovation for Biotherapies BIOSYNEX was founded in 2005 and is one of the most significant European manufacturers and provider of rapid membrane tests in the in-vitro diagnostic market. By staying close to our customers and business partners we are aware of the needs and expectations they may have of our products and services. Listening to their voice, together with the help of our Research and Development laboratories in France and our state of the art manufacturing facilities, allows us to identify new applications in rapid testing, develop and launch innovative products and provide high quality services. Our aim is to … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 69 | |
Roowin Small molecule GLP/GMP manufaturing Roowin is a privately owned Contract Research Organisation (CRO) headquartered at Riom, Auvergne, France. Its core business being in high value added fine chemistry, Roowin offers services in the following areas: • GMP synthesis • Clean room synthesis • Lead optimization • Scale up, process development • Custom synthesis • Analytical chemistry services We are proud to be able to accompany our customers from early drug discovery over process development to medium-scale GMP production, supporting our operations by strong analytical chemistry capabilities. GMP production, Lead Optimization, Clean room synthesis, Custom Synthesis, scale up, and process development Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 23 | |
Voisin Consulting Life Sciences (VCLS) Global reference partner to expedite access of HealthTech products to regulated markets. From discovery to product launch and lifecycle management At VCLS (Voisin Consulting Life Sciences), regulatory science guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. Starting early in the process, from discovery to the patient, VCLS assists innovators in designing optimized product development plans and regulatory strategies, combining the health ecosystem with commercial success. With a presence in seven locations across three continents and over 200 employees, VCLS serves a broad range of healthtech developers and their investors. Together, we accompany global stakeholders to expedite HealthTech … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 9 | 1 | 7 | 214 | |
LFB Biomanufacturing Your CDMO partner for antibodies and recombinant proteins LFB Biomanufacturing is an expert CDMO in the development and manufacture of recombinant proteins via cell culture, with specific know-how in the area of monoclonal antibodies (mAbs). LFB Biomanufacturing supplies a full range of bioproduction services, from the development of cell lines to the manufacturing clinical and commercial batches of active substances from biological products up to multiple pool of 2000L Cell Culture production capacities using Disposable Bioreactors Technology and exclusively Single-Use systems. The Alès site is regulary inspected by Customers as well as Health Agencies, including French-ANSM and US-FDA. LFB Biomanufacturing … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 0 | 3 | 150 | |
COVALAB Covalab is a French biotechnology company specialized in antibody engineering, founded in 1995. We are expert in the design and development of antibody (polyclonal, monoclonal scFv, FAb, VHH, recombinant antibodies) using antigen or DNA immunization. In addition, we offer purified and labeling antibodies, peptide synthesis for research use, diagnostic and therapeuthic. As a producer, we supply many distributors to sale our innovative and high quality antibodies. Wide range of those products are available in our website. The service activity of CovalAb represents the top of the scientific and technical iceberg which the team at CovalAb has put together. Indeed, the … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 2 | 3 | 23 | |
Aptys pharma The formulation company APTYS is a CRDO (contract research and development organization) which develops innovative products based of its expertise in pharmaceutical technologies and peptide delivery. APTYS offers ISO9001 aligned contract service, according to cGMP. Custom-made formulation development including in vivo/in vitro assessments. Semi solid dosage forms for topical and transdermal delivery. Injectable peptide depot formulations. Analytical development and validations. Quality control and ICH stability. Type: SMB Activities: biotech deeptech manufacturing | 9 | 1 | 9 | 14 | |
RD-BIOTECH Biomanufacturing, development & analytical services: Plasmids, Antibodies, Recombinant proteins, Cells - FastELISA kits French CRO Biotechnology 🔎 BIOMANUFACTURING: Plasmids (R&D and High Quality grades, And Now a pDNA GMP unit), Monoclonal antibodies, Recombinant antibodies (scFV, Fab, bispecific...), recombinant proteins (E.Coli, Cell free system, Yeast and mammalian cells), cells. 💡 Antibody engineering & molecular biology platforms: Antibody sequencing, vector design & cloning, Recombinant antibody production, Chimerization and Humanization, cell line development... ✍ Analytical services: immunoassays development, antibody characterisation, quality controls (R&D and high quality grades) FastELISA kits: Immunoglobulin quantification (human, mouse, rat, bovine), Mouse Immunoglobulin isotyping, Contaminant detection (Protein A), other … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 3 | 0 | 55 | |
Ariana Pharma The leading xAI-driven drug development company Ariana Pharma is a leading Artificial Intelligence (AI) drug development company. Using its KEM® Artificial Intelligence (xAI) technology, Ariana helps its partners introduce personalized medicine clinical trial design into their protocols and optimize clinical endpoints, identify biomarkers of therapeutic response and potential synergistic therapies. Ariana routinely collects and combines clinical data with omic data, immunological readouts (such as Fluorescence-Activated Cell Sorting (FACS)), microbiota, Patient Reported Outcomes (PRO) as well as Real World Evidence (RWE) data. Combining advanced data analytics, drug development, and regulatory expertise, Ariana helps translate findings into innovative clinical development plans and … Type: SMB Activities: biotech deeptech Technologies: A.I. Data Analytics | 6 | 0 | 3 | 37 | |
ILSA Manufacturer of Laboratory Instruments and Automated Systems iLsa is a key player in the field of laboratory instrumentation for in-vitro diagnostics with 40 years of experience and 10,000 instruments installed world-wide. 2 industrial sites : Besançon (France) : R&D and instruments manufacturing. Saint Ouen l’Aumône (France) : R&D and plastic consumables manufacturing in automated clean room. ILSA activity is based on two departments : iLsa Manufacturing designs and manufactures instruments and plastic consumables for In Vitro Diagnostic companies. iLsa Diagnostic is present on the international market - For Blood Transfusion Centers and Bio-Banks, iLsa Diagnostic is the market leader in … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 31 | |
CCPA GROUP Our expertise, your efficiency CCPA Group is a French company specialized in animal nutrition and health, with business and subsidiairies all over the world. For 50 years, CCPA Group has developed a wide range of products (premixes, piglet feeds, feed additives, dietetic feeds, hygiene products), services and expertises (zootechnical support, feed formulation, technological support, marketing and communication support...) for all farmers partners: feed manufacturers and distributors. CCPA Group anticipates feed sector and consumers expectations. Its major challenges are to innovate to improve customers competitiveness, nutritional and sanitary quality of animal products while integrating human health societal expectations and environmental preservation … Type: SMB Activities: agritech biotech Technologies: Bio sourced materials | 3 | 0 | 3 | 302 | |
BioFilm Control Expert in microbiota and biofilm BioFilm Control is a French biotech company expert in microbiota and biofilm since 2005. We work with R&D laboratories and marketing departments of pharmaceutical, cosmetic, oral care, veterinary, food, hygiene and food supplement industries to help them characterize and optimize the activity of their products on microbiota. | 2 | 1 | 1 | 6 | |
QIMA Life Sciences QIMA Life Sciences (formerly Bioalternatives, Synelvia, Newtone Technologies and Monasterium Laboratory) is a Contract Research Organization (CRO) specializing in cellular and molecular pharmacology. We offer assays ranging from in silico screening to non-invasive clinical sample bioanalysis, as well as in vitro and ex vivo assays. QIMA Life Sciences contributes to the development of in vitro methods, by offering solutions dedicated to preclinical research and to the development of drug candidates and to cosmetic active ingredients and formulations. QIMA Life Sciences can assist the health industry with its new strategic choices and helps the marketing and R&D departments to innovate in … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 0 | 6 | 150 | |
Scanelis Scanelis is a PCR diagnostic & research laboratory specialized in infectious diseases diagnostics in veterinary medecine : Detection & Quantification of pathogens in animals by quantitative PCR Scanelis performs day-to-day analyses in a secured lab, dedicated to this technology to provide veterinarians with fast and efficient diagnosis. Scanelis also provides support to Industry including: - PCR Diagnostics performed in accordance with a customer's specifications or prescribed quality plan, for instance with the European Pharmacopoeia recommendations. - Quality Control of biological products derived from animals - Custom-designed investigations: molecular typing of isolates or strains, infection monitoring and epidemiological monitoring, pathogens or … | 0 | 0 | 0 | 14 | |
Skyepharma Expert and agile fully integrated CDMO - specializing in classic and complex oral solid forms. Through many years of involvement and achievements in the pharmaceutical industry, Skyepharma’s development and manufacturing facility is eminently specialized in Complex Oral Solid Dosage Forms. We have the ability to provide customized solutions to our customers by positioning ourselves as a One-Stop-Shop player and a privileged partner offering a wide range of premium services. Our State-of-the Art CDMO facility close to Lyon (France) provides solutions bringing value to our clients at any stage of a product development lifecycle, from small scale programs up to commercial … Type: SMB Activities: biotech deeptech manufacturing Technologies: New Materials | 13 | 6 | 10 | 210 | |
Banook Group People serving Science, Science serving people Since 1999, Banook Group is one of the few established international providers of cardiac safety services, central imaging, endpoint adjudication, eCOA/ePRO and Virtual Clinical Trials. From early to late stage, generation and management, provisioning to scientific analysis, Banook Group and its medical expertise has become a key player for clinical trials. To learn more, please visit our website www.banookgroup.com Cardiac Safety, Endpoint Adjudication, Central Imaging, eCOA/ePRO, Virtual Clinical Trials, Clinical Project Management, Clinical Trial Provisioning, and Clinical Trial Support Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 5 | 1 | 5 | 58 | |
ETAP-Lab - Preclinical Efficacy CRO Fast-track your pipeline with preclinical excellence. in vitro & in vivo research services since 1991. ETAP-Lab provides preclinical models and services in the fields of Dermatology, Stroke and Neurodegenerative Diseases. The company has strong expertise in the field of Dermatology research and offers a large portfolio of original in vivo rodent models such as chronic skin inflammation, ischemic ulceration, psoriasis, hyperkeratosis, wound healing, atopic dermatitis, actinic keratosis, skin cancer... ETAP-Lab is also leader in the field of preclinical stroke research with a unique model portfolio consisting of innovative and translational models proposed under the brand Strok@lliance. With more than 2 … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 2 | 4 | 36 | |
BioCytex BioCytex is a contract research organization specializing in biomarker detection and analysis of normal and pathological cells in whole blood, bone marrow and other tissue samples. With over 20 years of experience in flow cytometry, we have a wide range of experience in developing and validating assays to suit many different requirements including immunophenotyping, detection of intracellular / extracellular markers, antigen binding assays. With the capacity to simultaneously measure multiple parameters on hundreds of individual cells per second, flow cytometry is a powerful technology with a wide variety of applications in pharmaceutical development. BioCytex is working with worldwide pharmaceutical companies. … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 23 | |
Vaiomer Pioneer in Blood and Tissue Microbiomes. Worldwide Expert in Microbiome Profiling from low bacterial biomass samples Pioneer and expert in blood and tissue microbiota, Vaiomer carries out microbiota studies, in the fields of human and animal health, for preclinical and clinical research, CROs, dermocosmetics, nutraceuticals and pharmaceutical / biotech companies. We perform microbiota studies from a very wide variety of biological samples (blood, adipose tissue, biopsies, tumors, and more classically skin, saliva, faeces, etc.): DNA extraction, quantification by qPCR, sequencing metagenomics, Bioinformatics, Biostatistics. Upstream and downstream of the studies: support for the experimental design and the drafting of study protocols, … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 8 | 1 | 3 | 7 | |
Paris Breast Rendez-Vous Save the date ! The 4th meeting will take place from May 13 to 15, 2020 The "Paris Breast Rendez-vous" is the first international conference devoted exclusively to breast surgery in France. Well known international surgeons will present the latest advances in aesthetic and reconstructive breast surgery. The "Paris Breast Rendez-Vous" is a unique opportunity to share our experiences through lectures, live surgeries, workshops and video sessions showing clinical cases. All aspects of breast surgery will be discussed with priority given to interactivity and discussions. The 4th edition will be held from May 13th to 15th 2020 at New Cap … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 0 | 0 | 0 | 1 | |
Five Alarm Bio Limited Boosting the body's ability to defend against the damage of aging Five Alarm Bio is a drug discovery company based in Cambridge, UK focusing on novel approaches to anti-aging, with broad potential therapeutic application. We are researching therapeutics that boost the body's ability to defend against the damage of aging. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 4 | |
Dualyx Discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. We aim to create long-lasting treatments for patients with a high unmet medical need. | 0 | 0 | 0 | 6 | |
Floating Genes Early cancer diagnosis in liquid biopsy by ultra-sensitive ctDNA sequencing. Early cancer detection from liquid biopsies | 9 | 8 | 1 | 3 | |
CircaGene CircaGene platform for personal genetic tests World's first Patented Incognito DNA Encryption with actionable result The mission of CircaGene is to provide world-class BioInformatics Services to protect and improve Public Health both at population and individual levels. Bioinformatics, Sequencing, Genomic, Genetic Data Privacy, Actionable Genomics, Genetic Coach, Optimised Lifestyle, Science in your side, DNApower, and Genetic Heroe Type: Startup Activities: deeptech biotech healthtech Technologies: Data Analytics | 0 | 0 | 0 | 8 | |
RHNANOPHARMA RH/Nanopharma is a Biopharma company dedicated to treating, preventing, slowing and reversing inflammatory diseases. | 0 | 0 | 0 | N/A | |
Eurofins Discovery Eurofins Discovery offers you a complete, single-source solution for drug discovery products and services. Eurofins Discovery has supported Drug Discovery research for >40 years. Our partners inspire us to innovate in the pursuit of life-changing cures. We provide our experience, depth, and breadth in the form of innovative testing services and product tools that support researchers as they accelerate the discovery and development of candidate molecules. Our global team of dedicated scientists, information analysts, and client support professionals make this mission possible. Our focus drives us to continually expand our portfolio of testing methods, tools, and services to enable real, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | 208 | |
NanoSpun Technologies We harness the power of biology to create revolutionary live-active cell-based products and solutions. NanoSpun is a global pioneer and frontrunner in the biotech, advanced materials and bioprinting spaces. We are leading the way to a whole new generation of cell-based products and solutions through the intelligent application of NanoSpun biological fabrics. No other company can do what we do. We encapsulate live and active biological cells and organisms, including bacteria, yeast, algae, plant cells, and mammalian to produce living tissues and fabrics with a wide application across many industries. Our current market focus is to revolutionize Skincare and Bioprocessing. … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 9 | |
Vytrus Biotech Natural Innovation for a Better Life. Applying the real power of plants to cosmetics through biotechnology We create natural active ingredients for skincare and haircare through innovative and sustainable biotechnology processes which obtain the real power of plants. Totipotent Cells Type: Startup Activities: deeptech cosmetics biotech Technologies: Bio sourced materials Synthetic Biology | 1 | 0 | 1 | 35 | |
Limula Cell & Gene Therapy: Automated. Scalable. Accessible Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics. Bioproduction, Immunooncology, Cell therapy, Biotechnolgoy, Manufacturing, and CAR-T Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 2 | 24 | |
Penrhos Bio A Joint Venture with Unilever PLC, creating a world free of harmful Biofilms though novel technology inspired by Nature. Were are a Joint Venture initiative with Unilever PLC formed in late 2019 with exclusive rights to the commercialise a new and novel technology based on furanone chemistry that inhibits Biofilms. Inspired by the biology of red seaweed, this single molecule platform offers a sustainable low-toxicity alternative to existing biocides. It has activity against bacteria by blocking quorum sensing and communication through multiple identified molecular targets in the bacteria, but is also effective against moulds and algae making this a unique … Type: Startup Activities: deeptech biotech Technologies: Bio sourced materials | 0 | 0 | 0 | 11 | |
Causeway Therapeutics Healthy Ageing Through Musculoskeletal Health Maintaining musculoskeletal health is the keystone of overall health as we get older. As we age our physical condition gradually deteriorates, leading to loss of strength, fitness and mobility. In most cases, this isn’t due to a simple decision to stop exercising. It is due to the breakdown of musculoskeletal function caused by disease. Musculoskeletal diseases such as osteoarthritis, tendinopathy and lower back pain are the primary causes of disability and early retirement in people over the age of 65. Currently, there are no approved disease-modifying drugs for these diseases, meaning that physical decline in … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 1 | 7 | |
Bionos Biotech S.L. Testing Efficacy - R&D Bioassays Bionos Biotech is a leading company in the design and development of Efficacy Studies for the Cosmetic, Agro-Food and Pharma Industries. Our Studies assess the efficacy of Active Ingredients and Final Products (undiluted), validating the functionality and mechanism of action in a novel, rigorous, fast and economical manner. Our services provide tailor-made and integral solutions through research, development and innovation. 10 Reasons to trust Bionos • Unique capacity for in vitro testing of both Active ingredients and Final Products (Undiluted). • Excellent Quality/Price ratio. • Thorough scientific Final Report. • Short time response: 4-6 weeks. … | 0 | 0 | 0 | 16 | |
PhD Trials® No miracles, just science® PhD Trials is an experienced International CRO that performs clinical assessment of safety and efficacy of cosmetics, food supplements and raw material products for the cosmetic industry (HRIPT, Patch test, Open Test studies, all the efficacy studies and other special projects). Cosmetic trials, Efficacy studies, Safety studies, In vivo, and Raw materials Type: Startup Activities: deeptech biotech cosmetics Technologies: New Materials | 0 | 0 | 0 | 46 | |
INVESTALGA AHTI S.L. Spanish bluebiotech- cutting edge seaweed cultivation and processing technology - sustainable cosmetic ingredients INVESTALGA is a Spanish innovative biotech specializing in the production of high quality bioactive compounds from green seaweeds available for use in nutrition, personal care and health markets. We are developing a scientific-technical-industrial base combining various disciplines: biotechnology, marine ecology, aquaculture, chemistry, nutrition and medicine, to credit and put value to the numerous possibilities derived from the unique biochemical composition of green seaweeds. At INVESTALGA we are fully committed to the preservation of coastal and marine environments, as well as the local communities associated with them, and … Type: Startup Activities: deeptech biotech Technologies: Bio sourced materials | 0 | 0 | 0 | 1 | |
skinbetter science Our award-winning products leverage decades of rigorous research to deliver remarkable results in skincare. In 2016, skinbetter science® set out to create a new paradigm in skincare, not only for patients, but for the physicians, nurses, aestheticians and surgeons who help patients achieve beautiful skin. Our award-winning products are backed by decades of rigorous clinical research (in powerhouse products like Restylane® and Dysport®) and furthered by a continued commitment to the study of skincare science. skinbetter products are purposefully developed and only available through authorized providers. This model supports physicians and consumers by establishing genuine patient-practice relationships. We’re not just … | 0 | 0 | 0 | 129 | |
Lactobio Microbial solutions and microbiome skincare with live bacteria In Lactobio we focus on the creation of new microbiome and microbial solutions to target and fight the problem of increasing infections caused by microorganisms being resistant to antibiotics. We work with the skin, vaginal, and gut microbiota to treat a variety of diseases – with projects spanning various pathogens. Lactobio has obtained very promising clinical results, with isolated lactic acid bacteria having a significant antibacterial activity against Staphylococcus aureus, Methicillin Resistant Staphylococcus aureus (MRSA) and other pathogens. | 0 | 0 | 0 | 7 | |
Personalized Stem Cells, Inc StemInsure®: Your Younger Cells For Life® Personalized Stem Cells, Inc. (PSC) is raising the standard of Stem Cell therapy. We are committed to providing high-quality stem cell processing services, as well as excellent technical, clinical, and regulatory support to physicians, clinical investigators, and patients. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 4 | |
Palette Dentals Making Smiles Equal and Healthier Palette is a research project developing new dental care products that would offer a better solution for your health in contrast to the existing ones and provide the necessary dental protection to every family in the world, inclusive of these who can’t afford it yet. | 1 | 0 | 1 | 1 | |
Orphazyme A/S Our vision: To profoundly impact the lives of patients with orphan diseases and their families Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases. Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 1 | 14 | |
Havas Health Network Havas Health Network unites Havas Life, Havas Lynx, and Jacques, all wholly owned health and communications networks, with the consumer health businesses and practices of Havas Creative Group. The network's approach is centered around making a meaningful difference and has the talent, tenacity, and technology that health companies, brands, and people need to thrive in today's world. For more information, visit www.HavasHealth.com. | 3 | 2 | 3 | 33 | |
AZELEAD An innovative drug discovery technology Good morning and welcome, we are pleased to introduce you to our structure. AZELEAD has developed ZebraScreen and ZebraTox, an innovative methodology for rapid and accurate assessment of the efficacy and toxicity of a drug In the past few years, we have seen a lot of attrition in the development of new drugs, with a failure rate of nearly 84% attributed to the low benefit of efficacy / toxicity. Three therapeutic areas are mainly affected by this decrease: oncology (failure rate of 29.5%), neurology (failure rate of 14%), and infectious diseases (failure … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
Mablink Bioscience Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 9 | 10 | 35 | |
Physics for Medicine Paris Inserm, ESPCI Paris-PSL, CNRS - Invent the future of biomedical technologies Physics for Medicine Paris is a French academic research institute dedicated to develop non-invasive technologies for medical imaging and therapy based on innovative concepts of wave physics. Type: Startup Activities: deeptech biotech healthtech | 4 | 2 | 2 | 23 | |
Lys Therapeutics First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle neurodegeneration. Lys Therapeutics is a pioneering biotechnology company revolutionizing the treatment of patients with neurodegenerative or neurovascular diseases by targeting blood-brain barrier (BBB) dysfunctions and neuroinflammation. In the pathophysiology of various neurological diseases such as stroke, multiple sclerosis, and Parkinson's disease, the hyperactivation of endothelial NMDA receptors (NMDAr) by tissue plasminogen activator (tPA) overexpressed in these patients leads to the degradation of tight junctions and BBB dysfunction, allowing the transmigration of inflammatory cells and toxic molecules into the brain parenchyma, triggering excitotoxicity and neuroinflammation, major contributors to neurodegeneration. Lys Therapeutics' lead … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 20 | 5 | 14 | 12 | |
Woodoo Augmented wood / Decarbonized materials for a new industrial revolution. Woodoo is unlocking the future of construction—leading the way toward more sustainable, resilient cities. How? By transforming underutilized hardwood into a cutting-edge wood composite material: STACK. STACK redefines what wood can do, providing a low-carbon and high-performance alternative to steel, aluminum and concrete for cladding and structural building applications. Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Decarbonization New Materials | 67 | 25 | 53 | 48 | |
Vivet Therapeutics Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression. Gene Therapy Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 1 | 2 | 32 | |
Data&Data - The intelligence of luxury Empowering brands with AI to curb the online grey market, capture resale trends, and attain competitive intelligence Founded in 2012, Data&Data is specialised in the luxury sector from watches and leather goods to fragrances. We help key decision makers to understand the ever-changing dynamics of the global online market. This enables them to make more informed and effective strategies. Data&Data is a privately held company, headquartered in Paris, France. Take a look at our blog on medium.com/@DATAANDDATA Big data, Analytics, Consulting, Data Management, Innovation, Information Management, Data science, Statistics, Datamining, Predictive analysis, Ecommerce Counterfeit Detection, Business intelligence, Artificial intelligence, Luxury, … Type: Startup Activities: deeptech fashtech biotech it services Technologies: Data Analytics A.I. - Image Processing A.I. - Deep Learning A.I. A.I. - Machine Learning | 8 | 2 | 6 | 10 | |
GlioCure A preclinical-stage drug-development company specialized in neuro-oncology GlioCure, a spin-off company of Angers and McGill Montreal universities, aims to treat glioblastoma that causes 200,000 deaths worldwide each year. To overcome this challenge, GlioCure is hyper-specialized and develops glioblastoma-specific drugs. GlioCure is currently focusing on the development of GC01, an anti-glioblastoma peptide discovered by Joël Eyer, Director of Research from INSERM, and covered by two patent families for which GlioCure owns worldwide exclusive rights. GlioCure's team has the experience and the know-how to ensure the successful completion of GC01’s development plan: Louis-Marie is a biotech entrepreneur with 15 years of experience … Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 12 | 7 | 7 | 5 | |
iligo Agence d'études et de conseils en marketing iligo is an award-winning research agency and consultancy focused on understanding new consumer behaviors and assessing the effectiveness of marketing activities for brand building. iligo clients include multi-national advertisers, media companies and advertising agencies. We leverage cutting-edge technologies and innovative techniques in data collection and analyses. Check out our work at www.iligo.fr. Specialties marketing communications research, passive advertising effectiveness measurement, cross-platform advertising assessment, mobile research, digital out-of-home research, neuroscience, econometrics marketing, communication, etudes, consommateurs, mesure passive de l'efficacité publicitaire, exposition publicitaire cross-plateforme, études digital out of home, neuroscience, économétrie, études mobiles, émotions, études … Type: Startup Activities: martech biotech deeptech Technologies: Affective Computing | 5 | 3 | 0 | 12 | |
FLUOPTICS Part of Getinge Fluoptics is a young and innovative company in the field of fluorescence imaging for both clinical and preclinical applications. In clinics, Fluoptics develops solutions to optically guide cancer surgery. This approach is based on an intra-operative near infra-red fluorescence detector and fluorescent probes which specifically target tumors. This technology, extensively tested on animals, drastically improves cancer surgery in providing surgeons with an acute delineation of cancerous nodules during the surgery. Fluoptics develops and markets the Fluobeam, a unique fluorescence imaging system with an open design and an excellent sensitivity in the near infra-red spectrum. The company also proposes near infra-red … | 5 | 6 | 1 | 29 | |
Cherry Biotech Alternative to Animal Testing for Drug Development Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing. Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates. By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 | 0 | 23 | |
nextProtein Feeding the future. The world’s population is estimated to reach more than nine billion by 2050. Global food production will have to increase by 70 per cent to feed everyone. Meanwhile one third of all food produced is wasted. At nextProtein we’re driven by a personal desire to address land and resource scarcity and feed a rising population sustainably. nextProtein can produce the equivalent amount of protein from 100sqm as 100ha of soya field. Founded by couple Syrine Chaalala and Mohamed Gastli, we produce insect-based protein for animal feedstocks with a negligible carbon footprint, at a lower cost and with … Type: Startup Activities: cleantech biotech deeptech greentech Technologies: Bio sourced materials | 16 | 3 | 7 | 50 | |
Pixium Vision S.A. Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons ! One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission … Type: Startup Activities: healthtech biotech deeptech manufacturing Technologies: Affective Computing A.I. Solar Technologies Synthetic Biology Wireless | 10 | 7 | 3 | 22 | |
FERMENTALG [Automatic translation follows] ALGAE, YOU CAN TRUST About Fermentalg: Based in Libourne (France), Fermentalg is an industrial biotechnology company, specialized in the production of oil rich in fatty acids (omega-3), proteins and natural pigments (phycocyanin) by fermentation of microalgae. Fermentalg offers innovative products in the global market such as Food, Feed and Environment. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, www.fermentalg.com About Fermentalg: Based in Libourne (France), Fermentalg is an industrial biotechnology company, specialized in the production of oil rich in fatty acids (omega-3), proteins and natural pigments (phycocyanin) by fermentation of microalgae. … Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials | 17 | 9 | 8 | 90 | |
Bioxis Pharmaceuticals #BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid Type: Startup Activities: healthtech deeptech biotech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 28 | |
CHAIN Biotechnology Ltd Superior and effective microbiome therapeutics CHAIN Biotechnology was founded in 2014, by serial entrepreneur Dr Edward Green, to exploit the therapeutic potential of Clostridia bacteria found in the human gut microbiome. CHAIN has built an impressive technical team of molecular biology, microbiology, microbiome and fermentation specialists focused on the biotechnology development of Clostridia. In addition, CHAIN leverages synthetic biology expertise from the Synthetic Biology Research Centre at the University of Nottingham. CHAIN has developed a proprietary microbial platform for drug delivery. The platform builds on core engineering skills and involves the development and use of engineered Clostridia to deliver specific … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 11 | |
Eligo Bioscience Precision medicines for the microbiome Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing. | 19 | 12 | 4 | 43 | |
Acticor Biotech To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 14 | 11 | 6 | 34 | |
lifeina Creators of the world's smallest fridge, designed to keep your medication at a constant temperature wherever you may go. Our future is one in which the lives of medication users are not dictated by their health. A future where you have the freedom to take control by using the right tools. ___ Without flawless execution, ingenious ideas might as well remain dreams. We honour our reputation and strive to be industry leaders. In doing so, we keep our small team flexible enough to listen and respond to your needs directly. So, when you speak to one of us, you’re speaking … Type: Startup Activities: healthtech biotech deeptech | 5 | 4 | 0 | 7 | |
Origem Sustainable Sourcing Fulfill companies’ sourcing ambitions by bringing them closer to sustainable solutions Origem guides your company implementing a sustainable sourcing strategy. Today, having a sustainable and traceable sourcing strategy is both a strength and a competitive advantage. Tomorrow, it will be the norm: requirements related to traceability and social and environmental production conditions of raw materials will be as important as quality and prices. Origem wants to embody the companies’ shift towards models that will transcend Human and Nature’s strength At Origem ... • We look for exemplary raw materials; whether mineral, plant or animal • We identify and connect the … Type: SMB Startup Activities: biotech consulting deeptech fashtech Technologies: Decarbonization | 9 | 1 | 8 | 4 | |
Manzalab DIGITAL EXPERIENCING PIONEER Manzalab Group is a digital experiences designer. Since 2010, we use neuroscience research scientific rigor and technological developments to serve all sorts of creativity. With offices in Paris, Aix-en-Provence and Singapore, our ecosystem comprises six entities, six different but complementary excellence centers: Manzalab, Manzavision, Akenomy, Perfect Industry, CyberZen and Longue-Vue. Together, we create new digital experiences covering several different areas such as: training, communication, design, industry, cyber-security and entertainment. At the forefront of Collaborative VR, we design our experiences for PCs, tablets and mobile phones as well as for virtual and augmented reality environments. Our skills The … Type: Startup Activities: deeptech biotech games transporttech Technologies: VR Affective Computing Cybersecurity Drones Sensors | 18 | 4 | 14 | 27 | |
HudsonAlpha Institute for Biotechnology Science for Life HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to developing and applying scientific advances to health, agriculture, learning, and commercialization. Opened in 2008, HudsonAlpha’s vision is to leverage the synergy between discovery, education, medicine, and economic development in genomic sciences to improve the human condition around the globe. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. The state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education and fosters … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech healthtech deeptech | 12 | 3 | 10 | 222 | |
IrsiCaixa Leading international research centre in infection and immunity. CERCA centre. IrsiCaixa is a leading research institute in infections and immunity, jointly driven by the "la Caixa" Foundation and the Department of Health of the Government of Catalonia. Established in 1995 as a private non-profit foundation, with the primary goal of finding a solution to the then-devastating HIV/AIDS pandemic, IrsiCaixa brings together extensive knowledge in the field of infectious diseases and the immune system. While maintaining a strong commitment to eradicating HIV, more than 100 dedicated researchers explore other viral, bacterial, and fungal infections with significant clinical impact, such as COVID-19, … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 8 | 1 | 4 | 111 | |
Farmabios, an Axplora company We supply the world with active pharmaceutical ingredients Farmabios is a leading global manufacturer of highly potent active pharmaceutical ingredients. With decades of steroid and complex chemistry expertise, and newly opened research and development projects in various fields, Farmabios provides bespoke products and solutions, understanding customer needs. Steroids, Chemistry, Active Pharmaceutical Ingredients, Hormones, Drug Substances, Healthcare, Pharmaceuticals, and Bespoke products Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 0 | 107 | |
P-BIO - Associação Portuguesa de Bioindústria A nossa missão é unificar e afirmar o sector da Biotecnologia & Ciências da Vida em Portugal. P-BIO - Portugal’s Biotechnology Industry Organization is the only association that brings together the vast majority of companies linked to the biotechnology and life sciences sector. Since it was founded in 1999, it has been the cornerstone for development and support of biotechnology in Portugal. P-BIO seeks to develop an environment that is favourable to the creation and growth of start-ups, promoting their corporate development domestically and internationally. While developing this ecosystem, it contributes to raising the profile of this sector and its … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech | 2 | 0 | 1 | 9 | |
Advanced Instruments, LLC Our focus on service, quality, and reliability has made Advanced Instruments a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries for more than 65 years. Globally, we provide innovative technologies aligned with the needs of the markets we serve, helping to improve efficiency, enhance productivity, and ensure best-in-class performance. Our Solentim portfolio of best-in-class imaging and single-cell deposition technologies enables the clonal isolation, outgrowth, and characterization of the highest value cells for monoclonal antibody upstream development and cell and gene therapy. Our robust line of micro-osmometers is built specifically for … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 1 | 483 | |
Caudalie Effective, clean, natural & sustainable skincare founded by Mathilde Thomas. 1% for the Planet member since 2012. Caudalie is a French skincare brand created by Mathilde and Bertrand Thomas in Bordeaux in 1995. All products are developed using natural ingredients from the vine and grapes. Caudalie's mission? To become the most effective clean and natural brand, and the most environmentally-friendly beauty brand. Beauty, Vinotherapy, Skincare, and CleanBeauty Type: Large company Activities: cosmetics biotech deeptech | 11 | 7 | 3 | 1,155 | |
CARPEM - CAncer Research for PErsonalized Medicine [Automatic translation follows] Research program dedicated to the development of new personalized treatments against cancer. Since 2011, 8 Integrated Cancer Research Sites (SIRIC), including CARPEM (CAncer Research for PErsonalized Medicine), have been labeled. They must offer cancer research new operational conditions in order to optimize and accelerate the production of knowledge and promote its dissemination and application in the management of cancers. In 2017, INCa launched a new labeling campaign for (SIRIC). After the success of the first program, CARPEM was labeled for the second time, which demonstrates the excellence of the collaborative work of our teams. The CARPEM, led … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech healthtech deeptech | 6 | 1 | 6 | 6 | |
inven Some things cannot be comprised especially quality of life saving drugs, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That`s why, we at Inven, are committed to apply science and our resources, for providing most innovative and quality products. We strive to provide access to safe, effective and affordable medicines to the people who need them. With a strong research oriented work culture, state-of-the-art production facility and end-to-end product development capabilities - Inven is recognized as a leading, ISO 9001-2000 and WHO GMP certified, IV fluid manufacturer in the international and domestic … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 2 | 1 | 0 | 33 | |
Floré by Sun Genomics The Best Custom Probiotics For A Healthy Gut are the Ones Made Specifically For You. The microbiome is the new frontier gut health and changes to your microbiome signature is now being understood as a central conduit of health and disease. IBD, IBS, Crohn's, colitis, type I diabetes, arthritis, metabolic syndrome, and several autoimmune disorders have all been associated with microbiome changes also known as dysbiosis. When you total the number of individuals affected by these diseases, over 80% Americans suffer from dysbiosis annually. With this much science there still aren't real solutions for dysbiosis. And since dysbiosis is the … Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics | 4 | 1 | 3 | 21 | |
Innomy Innovation & Mycology | Empowering The Fungi World Innomy develops global solutions for the food industry such as meat analogues or functional flours, always using sustainable biotechnological processes based on fungal mycelia and revaluing by-products from various industries as raw materials. Mycelium, Nutrition, Food Tech, Wet Protein, Functional Flours, Meat Analogues, Fungi , Biotech, Healthy Food, Umami, Sustainable, Science, Natural Products, Protein, Food Industry, By-products, Functional Food, Super Food, Fungi Based Meat, Fungi Meat, Fungi Food, and Mushroom Meat Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials | 3 | 1 | 3 | 6 | |
Chi Botanic We're developing the world's first synthetic biology pipeline to leverage the power of the plant cell. #IndieBio class 9 The Plant Cell Company! Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
myNEO Therapeutics Innovating immunotherapies, transforming tomorrow. myNEO Therapeutics is a distinguished biopharmaceutical powerhouse, dedicated to pioneer breakthrough immunotherapies to fight cancer. myNEO Therapeutics is leveraging its ImmunoEngine discovery platform to tap into novel promising tumor targets found in the dark genome – named camyotopesTM – which have the potential to unlock immunotherapy for large patient populations who currently do not respond. In parallel, the service angle of myNEO Therapeutics, myNEO Intelligence, assists biopharma companies in transforming their decision-making process from trial & error to data-driven decisions using an AI-powered platform. Deriving insights from its expansive library of clinical and molecular data, myNEO … Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology | 4 | 1 | 3 | 16 | |
EyeD Pharma Delivery of vision care EyeD Pharma is a clinical stage pharmaceutical company dedicated to improving the life of patients suffering from ophthalmic diseases with unmet medical needs such as glaucoma or dry eye. We develop innovative therapeutic solutions based on sustained release polymeric micro-implants and inserts. Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 5 | 1 | 5 | 67 | |
AbilityPharma Ability Pharmaceuticals is a clinical-stage biopharmaceutical company committed to develop first-in-class therapies that address unmet medical needs in the oncology space. AbilityPharma's is currently conducting, with ABTL0812, the most advanced asset, an international multi-center, double-blind, placebo-controlled phase 2b clinical trial in patients with metastatic pancreatic cancer to investigate ABTL0812 as first-lin therapy in combination with FOLFIRINOX chemotherapy. The study includes reference centers in Spain, France, United States and Israel. ABTL0812 has finished with very positive results a phase 2a clinical trial as first-line therapy in endometrial cancer and in squamous NSCLC in combination with paclitaxel and carboplatin. The study included … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 3 | 24 | |
aptaTargets Pioneering therapies based on aptamer technology aptaTargets is a clinical stage biopharmaceutical company focused in developing therapeutic applications based on aptamer technology. Our candidates are neuroprotectants and immunomodulators being developed from preclinical stages up to clinical proof-of-concept. Biopharmaceutical, Biotechnology, Aptamers, Immunology, Stroke, and Inflammatory diseases Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 11 | |
Kyomei Animal Identical, Plant Grown Kyomei is a molecular farming and biotechnology start-up that focuses on the production of animal-identical proteins, pigments, ingredients and molecules using the power of plants, photosynthesis, and molecular biology. We aim to fundamentally transform agriculture and the food industry by decoupling the deleterious impact of animal agriculture from its byproducts and offering a more compelling, lower cost and sustainable means of production. Animal-identical benefits. Plant-grown production. Agtech, Bioengineering, Molecular Farming, Alternative Protein, Ingredients, Innovation, Biotechnology, Foodtech, Plant-based, Plant Molecular Farming, Genetic Editing, CRISPR, Downstream Processing, Plant Transformation, Protein, Protein Extraction, and Leaf Protein Type: Startup Activities: deeptech biotech foodtech Technologies: Synthetic Biology | 0 | 0 | 0 | 10 | |
Inoviv Accelerating the Development of New Medicines with Targeted Proteomics Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development. Proteomics, Biomarker Discovery, Translational Biomarkers, Mass Spectrometry, Targeted Proteomics, Discovery Proteomics, Biomarkers, Precision Medicine, Proteomic Analysis, Proteome Profiling , Quantitative Proteomics, Liquid Chromatography Mass-Spectrometry (LC-MS), Post-Translational Modifications (PTMs), Quantitative Biomarkers, Clinical Proteomics, Immuno-Precipitation Mass Spectrometry (IP-MS), Proteins, LC-MS Proteomics, Proteomics Services, and Protein Identification Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 34 | |
STALICLA Bringing Precision Medicine to patients with Neurodevelopmental Disorders, including Autism Spectrum Disorder STALICLA SA is a Swiss clinical-stage biopharmaceutical company pioneering Neuro Precision Medicine in neurodevelopmental and neuropsychiatric disorders. With state-of-the-art technology platforms and clinical trials for Autism Spectrum Disorder (ASD) and Substance Use Disorder (SUD), STALICLA is changing the landscape of brain disease treatments. Neurodevelopmental Disorders: To propel neurodevelopmental research, STALICLA have identified patient subgroups and their matching candidate drugs within Autism Spectrum Disorder using its trailblazing, multi-omics DEPI platform. STALICLA is currently preparing Phase 2 trials for STP1, STALICLA's first patient subgroup-matched precision treatment. Substance Use Disorder research: … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 29 |